These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9273241)

  • 1. [Atenolol in treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1996 Dec; 1(6):428-30. PubMed ID: 9273241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atenolol in the treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1998 Feb; 4(20):89-91. PubMed ID: 9591440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of atenolol in chronic pulmonary patients with airway obstruction].
    Vancrombreucq JC; Schandevyl W
    Lille Med; 1978; 23(7):506-12. PubMed ID: 31524
    [No Abstract]   [Full Text] [Related]  

  • 4. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol is dead: long live beta-blockade.
    Cockcroft JR
    J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
    Dotzer F; Gromer H
    Fortschr Med; 1993 Aug; 111(24):382-4. PubMed ID: 8104853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequently used beta-blockers and circulating thyroid hormones].
    Custro N; Scafidi V; De Francisci MC
    Minerva Endocrinol; 1986; 11(3):185-9. PubMed ID: 2879217
    [No Abstract]   [Full Text] [Related]  

  • 11. Atenolol versus other beta-adrenergic blockers.
    Aursnes I; Osnes JB
    J Am Coll Cardiol; 2009 Jun; 53(22):2101-2; author reply 2106-7. PubMed ID: 19477363
    [No Abstract]   [Full Text] [Related]  

  • 12. The place of beta-blockers in cardiovascular medicine.
    Cruickshank JM
    Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060
    [No Abstract]   [Full Text] [Related]  

  • 13. [Doubt about atenolol in the treatment of hypertension. Beta blockers, diuretics and the aged].
    Tidsskr Nor Laegeforen; 1992 Mar; 112(8):1058-9. PubMed ID: 1348154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doubt about atenolol in the treatment of hypertension. Beta blockers, diuretics and the aged].
    Tidsskr Nor Laegeforen; 1992 Mar; 112(8):1058. PubMed ID: 1348153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta blockers today].
    Nieminen MS; Partanen J
    Nord Med; 1992; 107(5):150-2, 156. PubMed ID: 1351282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The beta-blockers. Introduction].
    Castaigne A
    Rev Prat; 1984 Apr; 34(19):903-4. PubMed ID: 6144158
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
    J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.